Lung and Breast Cancer Prevention by an Integrated Intervention of Maternal Smoking Cessation and Breastfeeding
This pilot clinical trial aims to integrate maternal smoking cessation and breastfeeding interventions to enhance both cancer prevention behaviors. The investigators will recruit 40 daily smoking women in their early pregnancy and randomize them into the integrated intervention or control group. Main outcomes include smoking abstinence and breastfeeding rates at 6 months postpartum.
Checked against the public recordLast updated Apr 17, 2025 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Prevention
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Xiaozhong Wen
- Interventions being studied
- Behavioral: Integrated intervention of smoking cessation and breastfeeding; Behavioral: Attention placebo control
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Be 18 years or older * At ≤28 weeks of pregnancy * Daily smoking cigarettes and/or cigars in the past 7 days * Be able to read, listen, and talk in English Exclusion Criteria: * Being diagnosed with cancer * Current heavy drinking (more than 2 drinks a day) * Current use of illicit substances * Medical conditions contraindicating breastfeeding such as HIV infection, active tuberculosis, and breast removal
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Division of Behavioral Medicine Department of Pediatrics Jacobs School of Medicine and Biomedical Sciences State University of New York at BuffaloBuffalo, New York
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Apr 17, 2025. Always confirm current availability with the study team.